Cargando…
From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
BACKGROUND: Despite screening campaigns, cervical cancers remain among the most prevalent malignancies and carry significant mortality, especially in developing countries. Most studies report outcomes of patients receiving the usual standard of care. It is possible that these selected patients may n...
Autores principales: | Espenel, Sophie, Garcia, Max-Adrien, Trone, Jane-Chloé, Guillaume, Elodie, Harris, Annabelle, Rehailia-Blanchard, Amel, He, Ming Yuan, Ouni, Sarra, Vallard, Alexis, Rancoule, Chloé, Ben Mrad, Majed, Chaleur, Céline, De Laroche, Guy, Guy, Jean-Baptiste, Moreno-Acosta, Pablo, Magné, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796580/ https://www.ncbi.nlm.nih.gov/pubmed/29394940 http://dx.doi.org/10.1186/s13014-018-0963-8 |
Ejemplares similares
-
Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
por: Espenel, Sophie, et al.
Publicado: (2018) -
Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index
por: Rancoule, Chloé, et al.
Publicado: (2017) -
The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
por: Vallard, Alexis, et al.
Publicado: (2017) -
Healing touch in radiation therapy: is the benefit tangible?
por: Guy, Jean-Baptiste, et al.
Publicado: (2017) -
Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker
por: Vallard, Alexis, et al.
Publicado: (2018)